| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |